Search
Search Results
##search.searchResults.foundPlural##
-
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
999PDF: 537HTML: 7810 -
-
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1376HTML: 394PDF: 819 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2336PDF: 935HTML: 304 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
975PDF: 361HTML: 196 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1062PDF: 1065HTML: 442 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2180PDF: 817HTML: 952Untitled: 268 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
771PDF: 582Suppl. Files: 123HTML: 91 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1998PDF: 1133HTML: 626 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3735PDF: 1246HTML: 1719Untitled: 162 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2801PDF: 1007HTML: 5520 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1310PDF: 1203HTML: 447 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1105PDF: 485HTML: 8164 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1612PDF: 806HTML: 165 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2082PDF: 1517HTML: 285 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3879PDF: 1475HTML: 8513 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1028PDF: 635HTML: 78 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1281PDF: 721HTML: 322 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1495PDF: 542HTML: 716 -
-
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1823PDF: 797HTML: 3600 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3510PDF: 883HTML: 1653figure 1: 165Untitled: 188 -
-
Mantle cell lymphoma relapsing at the lymphedematous arm.
1698PDF: 696HTML: 3795 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2757PDF: 1009HTML: 411TABLE: 188FIGURES: 252 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4318PDF: 1489HTML: 1547Untitled: 225 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
630PDF: 221Html: 32 -
IMMUNOLOGY OF TUBERCULOSIS
5294PDF: 2002HTML: 7319Untitled: 195







